Clinical Outcomes of Definitive Radiation Therapy for Early Glottic Cancer Using Different Techniques: A Seven-Year Experience at a Tertiary Care Center in North India

Aim The aim of this study was to evaluate overall survival (OS) in patients with early-stage glottic cancer treated with definitive radiation therapy (RT) and to assess local control (LC), disease-free survival (DFS), prognostic factors, and acute toxicity. Materials and methods This retrospective cohort study included 50 patients with early-stage glottic cancer treated with definitive RT between January 2018 and December 2023. Follow-up continued until December 2025. Twenty patients received intensity-modulated RT (IMRT), and 30 received three-dimensional conformal RT (3DCRT). The median prescribed dose was 66 Gy. OS was the primary endpoint. Secondary endpoints were LC, DFS, prognostic factors, and acute toxicity. Results The median follow-up was 32 months (range, 1-66 months). Complete response was reported in 48 patients (96%), partial response in one patient (2%), and disease progression in one patient (2%), who developed brain metastasis. Locoregional recurrence occurred in one patient, and distant metastasis occurred in one patient. In univariate analysis, anterior commissure (AC) involvement and tumor stage were significantly associated with DFS and OS. In multivariable analysis, AC involvement was also significantly associated with LC. Median OS was 34 months. No grade 2 or 3 radiation toxicity was reported. Conclusions Definitive RT was associated with a high complete-response rate, and few recurrences were reported in this cohort. The study describes outcomes among patients treated with 3DCRT or IMRT but does not establish the superiority of either technique.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-11-16
DOI
https://doi.org/10.7759/cureus.119721
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical Outcomes of Definitive Radiation Therapy for Early Glottic Cancer Using Different Techniques: A Seven-Year Experience at a Tertiary Care Center in North India

Asifa Andleeb, Mushtaq Ahmad Sofi, Musaib Mushtaq, Mir Yasir et al.
2 links
Cureus
Head and Neck Cancer Studies
article

Clinical Outcomes of Definitive Radiation Therapy for Early Glottic Cancer Using Different Techniques: A Seven-Year Experience at a Tertiary Care Center in North India

Asifa Andleeb, Mushtaq Ahmad Sofi, Musaib Mushtaq, Mir Yasir, Shaheen Nazir, Ulfat Ara, Shahida Nasreen, Mohmad Hussain Mir, Malik Tariq Rasool, Kaneez Fatima, Rameez Raja, Sajad Mir
article en

Abstract

Aim The aim of this study was to evaluate overall survival (OS) in patients with early-stage glottic cancer treated with definitive radiation therapy (RT) and to assess local control (LC), disease-free survival (DFS), prognostic factors, and acute toxicity. Materials and methods This retrospective cohort study included 50 patients with early-stage glottic cancer treated with definitive RT between January 2018 and December 2023. Follow-up continued until December 2025. Twenty patients received intensity-modulated RT (IMRT), and 30 received three-dimensional conformal RT (3DCRT). The median prescribed dose was 66 Gy. OS was the primary endpoint. Secondary endpoints were LC, DFS, prognostic factors, and acute toxicity. Results The median follow-up was 32 months (range, 1-66 months). Complete response was reported in 48 patients (96%), partial response in one patient (2%), and disease progression in one patient (2%), who developed brain metastasis. Locoregional recurrence occurred in one patient, and distant metastasis occurred in one patient. In univariate analysis, anterior commissure (AC) involvement and tumor stage were significantly associated with DFS and OS. In multivariable analysis, AC involvement was also significantly associated with LC. Median OS was 34 months. No grade 2 or 3 radiation toxicity was reported. Conclusions Definitive RT was associated with a high complete-response rate, and few recurrences were reported in this cohort. The study describes outcomes among patients treated with 3DCRT or IMRT but does not establish the superiority of either technique.

Cureus
Sher-i-Kashmir Institute of Medical Sciences (IN)
Good health and well-being
Head and Neck Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon